XAnge is a European early-stage venture capital firm and the innovation-driven venture brand of the Siparex Group, based in Paris, Berlin, and Brussels. With over 20 years of experience and €800M under management, the firm backs visionary founders from Seed to Series B across sectors including AI, deep tech, cybersecurity, fintech, and sustainable technologies.
Average disclosed round size is $35.0M (across 37 rounds with reported amounts).
Portfolio
59
Fund Size
—
Top Stage
Series A
Last 12 Mo
3
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
72 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Sêmeia | Unknown | — | May 2026 |
 Vertical Compute | Seed | — | Jan 2026 |
| SSaporo | Series A | — | Dec 2025 |
 Animaj | Growth | $75M | Jun 2025 |
 Knowunity | Series B | — | Jun 2025 |
 Tomorro | Unknown | — | Mar 2025 |
| Vertical Compute | Seed | $20M | Jan 2025 |
 Gladia | Series A | $16M | Oct 2024 |
 SurgAR | Unknown | — | Sep 2024 |
 Sirona Technologies | Seed | $6.5M | Jun 2024 |
 Greenly | Series B | $52M | Mar 2024 |
 Airfocus | Series A | $7.5M | Jan 2024 |
 Estuaire | Seed | — | Jan 2024 |
| EEpoca | Unknown | — | Sep 2023 |
 Gleamer | Series B | $29.5M | Jun 2023 |
 Welcome to the Jungle | Series C | $55M | Jan 2023 |
 Vianova | Series A | $6.4M | Dec 2022 |
| SSaporo | Seed | — | Dec 2022 |
 Valuecase | Pre-Seed | — | Sep 2022 |
 Core Biogenesis | Series A | $10.5M | Jul 2022 |
| DDattak | Seed | — | Jun 2022 |
 Implicity | Series A | $23M | Apr 2022 |
 Synapse Medicine | Series B | $28M | Mar 2022 |
 Silvr | Series A | $20.6M | Feb 2022 |
 Request Finance | Seed | $5.5M | Jan 2022 |
Page 1 of 3
Top Co-Investors
Bpifrance13 shared
Station F5 shared
Korelya Capital4 shared
Kima Ventures4 shared
Serena4 shared
Eurazeo3 shared
Frst3 shared
Bpifrance Large Venture3 shared
Quantonation3 shared
Omnes Capital3 shared
BNP Paribas2 shared
CNP Assurances2 shared
Revaia2 shared
Satgana2 shared
ISAI2 shared
Headline2 shared
Daphni2 shared
Bristol Myers Squibb2 shared
Supernova Invest2 shared
Last updated: 7 September 2026